France
In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in inventive step analyses
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Despite a broader slowdown in US IP partner hiring in 2025, litigation demand drove aggressive lateral expansion at select firms
Exclusive in-house data uncovered by Managing IP reveals French firms underperform on providing value equivalent to billing costs and technology use
Sponsored
Sponsored
-
Sponsored by InlexIgor Charles of Inlex explains how the EUIPO Board of Appeal recognised the Givenchy 4G logo’s reputation in France, linking luxury goods to financial services under Article 8(5) of the EU Trademark Regulation -
Sponsored by InlexIgor Charles and Franck Soutoul of Inlex examine a Paris Court of Appeal ruling that fully invalidated a ‘Richard Mille’ trademark for fraud despite limits on protection based on reputation
-
Sponsored by Cabinet Beau de LoméniePatent experts from Beau de Loménie discuss the Unitary Patent Court and actions to be taken before its implementation
-
Sponsored by Cabinet Beau de LoménieNew rules now apply in France to inventions and software created by individuals who are neither private nor state sector employees, as Gaston Vedel of Cabinet Beau de Loménie explains
-
Sponsored by Cabinet Beau de LoménieFrancis Declercq of Cabinet Beau de Loménie looks at the key tax changes arising from the IP box regime in France
-
Sponsored by Cabinet Beau de LoménieAurélia Marie of Cabinet Beau de Lomenie considers bad faith trademark filing strategies in the EU
